logoTry Persana

Sensible Biotechnologies - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Sensible Biotechnologies including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Sensible Biotechnologies company logo

Unlocking the next generation of mRNA medicines.

Sensible Biotechnologies is building a platform for the scalable manufacturing of high-quality mRNA to unlock the next generation of mRNA medicines.

Headquartersnull, null
Team size1-50
Founded2021

What is Sensible Biotechnologies? - Company Overview & Details

Sensible Biotechnologies is Sensible Biotechnologies is building a platform for the scalable manufacturing of high-quality mRNA to unlock the next generation of mRNA medicines. Founded in 2021, the company is headquartered in null, null.

Who Founded Sensible Biotechnologies?

Sensible Biotechnologies was founded by Miroslav Gasparek, Marian Kupculak.

Who are the Key Executives at Sensible Biotechnologies? - Leadership Team

Sensible Biotechnologies is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Sensible Biotechnologies

Miroslav GasparekCEO

Chief Technology Officer (CTO) of Sensible Biotechnologies

Alain PralongCTO

About Miroslav Gasparek - CEO of Sensible Biotechnologies

Miroslav Gasparek serves as the Chief Executive Officer of Sensible Biotechnologies, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Sensible Biotechnologies Company Details & Key Information

Where is Sensible Biotechnologies located?

Sensible Biotechnologies is headquartered in null, null.

How many employees does Sensible Biotechnologies have?

Sensible Biotechnologies has 1-50 employees.

When was Sensible Biotechnologies founded?

Sensible Biotechnologies was founded in 2021.

Sensible Biotechnologies Official Website

How much funding has Sensible Biotechnologies raised?

Sensible Biotechnologies has raised $4.2 Million across 3 funding rounds. The most recent funding was completed on 2023-05-06.

Funding Overview

Sensible Biotechnologies has raised a total of $4.2 million in a pre-seed funding round led by BlueYard Capital.

$4.2 Million
Total Funding Raised
3
Funding Rounds
2023-05-06
Latest Round

Sensible Biotechnologies Funding History

Pre seed
2023-05-06
$4.2 Million

Who are the key investors in Sensible Biotechnologies?

Sensible Biotechnologies is backed by 1 key investors including BlueYard Capital. These investors focus on sectors.

Sensible Biotechnologies Investor Overview

1
Key Investors
1
Focus Areas
0
Notable Investments

Complete List of Sensible Biotechnologies Investors

BlueYard Capital

What sectors do Sensible Biotechnologies investors focus on?

The investors backing Sensible Biotechnologies primarily focus on sectors.

Featured Investor: BlueYard Capital

BlueYard Capital

What are Sensible Biotechnologies's future plans?

Future Plans Information Not Available

Detailed information about Sensible Biotechnologies's future plans and strategic initiatives is not currently available in our database.

What are the latest news about Sensible Biotechnologies?

Sensible Biotechnologies has 2 recent news updates covering key business developments and market activities.

Sensible Biotechnologies News Overview

2
Recent Articles
Active
Media Coverage
2023-04-02
Latest Update

What is Sensible Biotechnologies in the news for?

Sensible Biotechnologies is currently featured in news for Ginkgo Bioworks partners with Sensible Biotechnologies for in vivo mRNA manufacturing platform. and other significant business developments.

Recent News Articles About Sensible Biotechnologies

Article 1
2023-04-02

Ginkgo Bioworks partners with Sensible Biotechnologies for in vivo mRNA manufacturing platform.

Sensible Biotechnologies is partnering with Ginkgo Bioworks to develop an in vivo microbial mRNA manufacturing platform.

ginkgobioworks.com
Read News
Article 2
2024-02-27

Sensible Biotechnologies collaborates with Ginkgo in mRNA manufacturing enhancement.

Ginkgo Bioworks is working with Sensible Biotechnologies to develop an in vivo microbial mRNA manufacturing platform.

prnewswire.com
Read News

Sensible Biotechnologies FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Sensible Biotechnologies including information about founders, CEO, funding history, investors, headquarters location, and company details. 17 frequently asked questions covering key information about the company.

Sensible Biotechnologies Questions & Answers - Company Information

Q1

What is Sensible Biotechnologies?

Sensible Biotechnologies is building a platform for the scalable manufacturing of high-quality mRNA to unlock the next generation of mRNA medicines.

Q2

Who founded Sensible Biotechnologies?

Sensible Biotechnologies was founded by Miroslav Gasparek, Marian Kupculak.

Q3

Who is the CEO of Sensible Biotechnologies?

The CEO of Sensible Biotechnologies is Miroslav Gasparek. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Sensible Biotechnologies raised?

Sensible Biotechnologies has raised a total of $$4.2 Million across 3 funding rounds. The most recent funding was completed on 2023-05-06.

Q5

Who are the investors in Sensible Biotechnologies?

Sensible Biotechnologies's key investors include BlueYard Capital.

Q6

Where is Sensible Biotechnologies headquartered?

Sensible Biotechnologies is headquartered in null, null.

Q7

When was Sensible Biotechnologies founded?

Sensible Biotechnologies was founded in 2021.

Q8

How many employees does Sensible Biotechnologies have?

Sensible Biotechnologies has 1-50 employees.

Q9

What is Sensible Biotechnologies's official website?

You can visit Sensible Biotechnologies's official website at https://www.sensible.bio/.

Q10

What was Sensible Biotechnologies's latest funding round?

Sensible Biotechnologies's latest funding round was a Pre seed round of $$4.2 Million completed on 2023-05-06.

Q11

Who is founder?

Miroslav Gasparek

Q12

Who is cto?

Alain Pralong

Q13

What does the company do?

Sensible Biotechnologies is building a platform for the scalable manufacturing of high-quality mRNA to unlock the next generation of mRNA medicines.

Q14

How much funding?

$4.2 Million

Q15

Latest funding date?

2023-05-06

Q16

Who are the investors?

BlueYard Capital

Q17

Latest news?

Sensible Biotechnologies is partnering with Ginkgo Bioworks to develop an in vivo microbial mRNA manufacturing platform. Ginkgo Bioworks is working with Sensible Biotechnologies to develop an in vivo microbial mRNA manufacturing platform.

More Information About Sensible Biotechnologies

For additional details about Sensible Biotechnologies, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.